Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Days of Pheresis Needed for Harvesting CD34+ Cells for Autologous Hematopoietic Stem Cell Transplantation Is Associated with Speed of Neutrophil Recovery and the Development of Secondary AML/MDS.

Shahbaz Malik, Brian J. Bolwell, Robert Dean, Ronald Sobecks, Matt Kalaycio, John Sweetenham, Brad Pohlman, Steve Andresen, Lisa Rybicki, Shawnda Tench, Priscilla Figueroa, MD, Edward Copelan

Blood (2009) 114 (22): 2151.

https://doi.org/10.1182/blood.V114.22.2151.2151

Published: 2009

Journal Articles

Etoposide Priming in Patients with Lymphoma Improves Mobilization without An Increased Risk of Secondary Hematologic Malignancies.

Anuj Mahindra, MD, Brian J. Bolwell, Robert Dean, Matt Kalaycio, Belinda Avalos, Lisa Rybicki, Shawnda Tench, Patrick Elder, Ronald Sobecks, John Sweetenham, Brad Pohlman, Steve Andresen, Steve Devine, Edward Copelan

Blood (2009) 114 (22): 2264.

https://doi.org/10.1182/blood.V114.22.2264.2264

Published: 2009

Journal Articles

Multiple Unit Umbilical Cord Blood Transplantation with Total Body Irradiation, Etoposide and Antithymocyte Globulin for Adult Hematologic Malignancy Patients.

Ronald Sobecks, Edward Copelan, Matt Kalaycio, Medhat Askar, Lisa Rybicki, Sheila Serafino, Mary Serafin, Roger Macklis, Robert Dean, Brad Pohlman, Steve Andresen, Brian J. Bolwell

Blood (2009) 114 (22): 4344.

https://doi.org/10.1182/blood.V114.22.4344.4344

Published: 2009

Journal Articles

Length of Stay among Patients Undergoing Autologous Stem Cell Transplantation for Lymphoma:Predictive Factors and Prognostic Effect.

Anuj Mahindra, Brian Bolwell, Lisa Rybicki, Matt Kalaycio, Ronald Sobecks, Steve Andresen, Brad Pohlman, John Sweetenham, Edward Copelan, Robert Dean

Blood (2008) 112 (11): 2184.

https://doi.org/10.1182/blood.V112.11.2184.2184

Published: 2008

Journal Articles

No Impact of Postremission Consolidation Chemotherapy Before Allogeneic Transplant in Patients with First Remission Acute Myeloid Leukemia with Intermediate or High Risk Cytogenetics.

Lisa O. Sproat, MD, MSW, Brian Bolwell, Lisa Rybicki, Matt Kalaycio, Robert Dean, Ronald Sobecks, Brad Pohlman, Steve Andresen, Shawnda Sungren, Josephine Chan, John Sweetenham, Ed Copelan

Blood (2008) 112 (11): 2164.

https://doi.org/10.1182/blood.V112.11.2164.2164

Published: 2008

Journal Articles

Elevated Ferritin Is Associated with Poorer Survival Following Nonablative Allogeneic Transplantation.

Anuj Mahindra, MD, Ronald Sobecks, MD, Lisa Rybicki, MS, Stacey Brown, Brad Pohlman, MD, Matt Kalaycio, MD, Robert Dean, MD, Steve Andresen, DO, John Sweetenham, MD, Brian Bolwell, MD, Edward Copelan, MD

Blood (2007) 110 (11): 1986.

https://doi.org/10.1182/blood.V110.11.1986.1986

Published: 2007

Journal Articles

Risk Factors and Outcomes for Relapse after Autologous Stem Cell Transplantation for Hodgkin Lymphoma.

Robert M. Dean, MD, John W. Sweetenham, MD, Tao Jin, PhD, Stacey Brown, MS, Brad Pohlman, MD, Ronald Sobecks, MD, Matt Kalaycio, MD, Steve Andresen, MD, Edward A. Copelan, MD, Brian J. Bolwell, MD

Blood (2007) 110 (11): 1903.

https://doi.org/10.1182/blood.V110.11.1903.1903

Published: 2007

Journal Articles

When May Patients Be Considered Cured after Autografting for Hodgkin Lymphoma?.

Robert M. Dean, MD, John W. Sweetenham, MD, Tao Jin, PhD, Stacey Brown, MS, Brad Pohlman, MD, Ronald Sobecks, MD, Matt Kalaycio, MD, Steve Andresen, MD, Edward Copelan, MD, Brian J. Bolwell, MD

Blood (2007) 110 (11): 1909.

https://doi.org/10.1182/blood.V110.11.1909.1909

Published: 2007

Journal Articles

Comparison of 200 cGy vs. 400 cGy Total Body Irradiation (TBI) When Used with Fludarabine for Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation (RIC AHSCT).

Ronald Sobecks, Robert Dean, Lisa Rybicki, Josephine Chan, Karl Theil, Roger Macklis, Steve Andresen, Matt Kalaycio, Brad Pohlman, Christine Ferraro, Kelly Cherni, Laura Bernhard, John Sweetenham, Edward Copelan, Brian Bolwell

Blood (2007) 110 (11): 2003.

https://doi.org/10.1182/blood.V110.11.2003.2003

Published: 2007

Journal Articles

Pre-Transplant Hypogammaglobulinemia Influences Survival after Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT).

Ronald Sobecks, Matt Kalaycio, Lisa Rybicki, Josephine Chan, Robert Dean, Karen Sands, Mary Serafin, Jennifer Kosar, Steve Andresen, Brad Pohlman, Edward Copelan, Brian Bolwell

Blood (2007) 110 (11): 1979.

https://doi.org/10.1182/blood.V110.11.1979.1979

Published: 2007

Journal Articles

Long Term Follow Up with Etoposide Priming in Patients with Lymphoma.

Anuj Mahindra, MD, Brian Bolwell, MD, Brad Pohlman, MD, Lisa Rybicki, MS, Stacey Brown, Robert Dean, MD, Matt Kalaycio, MD, Steve Andresen, DO, Ronald Sobecks, MD, John Sweetenham, MD, Edward Copelan, MD

Blood (2007) 110 (11): 1895.

https://doi.org/10.1182/blood.V110.11.1895.1895

Published: 2007

Journal Articles

Prognostic Impact of Elevated Pretransplant Serum Ferritin in Allogeneic Hematopoietic Stem Cell Transplantation.

Anuj Mahindra, MD, Brian Bolwell, MD, Ronald Sobecks, MD, Lisa Rybicki, MS, Stacey Brown, Brad Pohlman, MD, Robert Dean, MD, Steve Andresen, DO, Matt Kalaycio, MD, John Sweetenham, MD, Edward Copelan, MD

Blood (2007) 110 (11): 1109.

https://doi.org/10.1182/blood.V110.11.1109.1109

Published: 2007

Journal Articles

Analysis of Factors Influencing Skin Toxicity after Autologous Hematopoeitic Stem Cell Transplant.

Anuj Mahindra, MD, Brian Bolwell, MD, Ronald Sobecks, MD, Lisa Rybicki, MS, Stacey Brown, Brad Pohlman, MD, Matt Kalaycio, MD, Robert Dean, MD, Steve Andresen, DO, John Sweetenham, MD, Edward Copelan, MD

Blood (2007) 110 (11): 2882.

https://doi.org/10.1182/blood.V110.11.2882.2882

Published: 2007

Journal Articles

Elevated Pretransplant Serum Ferritin in Autologous Stem Cell Transplant.

Blood (2007) 110 (11): 606.

https://doi.org/10.1182/blood.V110.11.606.606

Published: 2007

Journal Articles

Disappointing Outcomes of Peripheral T Cell Lymphoma after Autologous Stem Cell Transplantation.

Stephen D. Smith, MD, John William Sweetenham, MD, Lisa Rybicki, MS, Stacey Brown, BA, Robert M. Dean, MD, Matt Kalaycio, MD, Ronald Sobecks, MD, Steve Andresen, DO, Eric His, MD, Brad Pohlman, MD, Brian J. Bolwell, MD

Blood (2006) 108 (11): 5428.

https://doi.org/10.1182/blood.V108.11.5428.5428

Published: 2006

Journal Articles

A Quality of Life Assessment of Ablative Allogeneic Bone Marrow Transplant (BMT) Recipients One and Twelve Months after Transplant.

Brian Bolwell, MD, Linda McLellan, LISW, Larry Foster, Ph.D, Lisa Rybicki, Ronald M. Sobecks, MD, Brad Pohlman, MD, Steve Andresen, DO, Elizabeth Kuczkowski, Mary Serafin, R.N., Karen Sands, R.N., Jennifer Kosar, R.N., Stacey Brown, Jennifer Bates, Mikkael Sekeres, MD, MS, Jane Dabney, LISW, Erin Welsh, LSW, Matt Kalaycio, MD

Blood (2005) 106 (11): 1322.

https://doi.org/10.1182/blood.V106.11.1322.1322

Published: 2005

Journal Articles

Autologous Stem Cell Transplantation (ABMT) for Recurrent Hodgkin’s Disease from 1990–2005: Factors Contributing to Post-Transplant Relapse.

Brian Bolwell, MD, Brad Pohlman, MD, Matt Kalaycio, MD, Steve Andresen, DO, Elizabeth Kuczkowski, Stacey Brown, Jennifer Bates, Lisa Rybicki, Julie Curtis, R.N., Kimberly Bell, R.N., Ronald M. Sobecks, MD

Blood (2005) 106 (11): 2083.

https://doi.org/10.1182/blood.V106.11.2083.2083

Published: 2005

Journal Articles

Improved Post-Transplant Outcomes in Hematologic Malignancy Patients Undergoing Non-Myeloablative Hematopoietic Stem Cell Transplant (NMHSCT) Using a 400 cGy Total Body Irradiation (TBI) Dose with Fludarabine.

Ronald M. Sobecks, MD, Karl S. Theil, MD, Lisa Rybicki, Roger Macklis, MD, Brad Pohlman, MD, Steve Andresen, DO, Stacey Brown, Elizabeth Kuczkowski, Kelly Cherni, R.N., Janet Baker, R.N., Laura Bernhard, R.N., Matt Kalaycio, MD, Brian Bolwell, MD

Blood (2005) 106 (11): 3674.

https://doi.org/10.1182/blood.V106.11.3674.3674

Published: 2005

Journal Articles

High Incidence of Extramedullary Relapses Following Allogeneic Bone Marrow Transplant (Allo-BMT) in Adults with Acute Lymphoblastic Leukemia.

Ahmed Absi, M.D., Brian J. Bolwell, M.D., Ronald Sobecks, M.D., Brad Pohlman, M.D., Steve Andresen, D.O., Lisa Rybicki, Matt Kalaycio, M.D.

Blood (2004) 104 (11): 5117.

https://doi.org/10.1182/blood.V104.11.5117.5117

Published: 2004

Journal Articles

The Prognostic Importance of Pre and Post Dendritic Cells in Autologous Transplantation for Diffuse Large B Cell Lymphoma.

Brian J. Bolwell, M.D., Brad Pohlman, M.D., Steve Andresen, D.O., Sheila Serafino, Ronald Sobecks, M.D., Elizabeth Kuczkowski, Julie Curtis, R.N., Lisa Rybicki, Jarek Maciejewski, M.D., PhD, Janet Baker, R.N., Kelly Cherni, R.N., Laura Bernhard, R.N., Matt Kalaycio, M.D., Eric Hsi, M.D., Karl Theil, M.D.

Blood (2004) 104 (11): 443.

https://doi.org/10.1182/blood.V104.11.443.443

Published: 2004

NARROW

Days of Pheresis Needed for Harvesting CD34+ Cells for Autologous Hematopoietic Stem Cell Transplantation Is Associated with Speed of Neutrophil Recovery and the Development of Secondary AML/MDS.

Etoposide Priming in Patients with Lymphoma Improves Mobilization without An Increased Risk of Secondary Hematologic Malignancies.

Multiple Unit Umbilical Cord Blood Transplantation with Total Body Irradiation, Etoposide and Antithymocyte Globulin for Adult Hematologic Malignancy Patients.

Length of Stay among Patients Undergoing Autologous Stem Cell Transplantation for Lymphoma:Predictive Factors and Prognostic Effect.

No Impact of Postremission Consolidation Chemotherapy Before Allogeneic Transplant in Patients with First Remission Acute Myeloid Leukemia with Intermediate or High Risk Cytogenetics.

Elevated Ferritin Is Associated with Poorer Survival Following Nonablative Allogeneic Transplantation.

Risk Factors and Outcomes for Relapse after Autologous Stem Cell Transplantation for Hodgkin Lymphoma.

When May Patients Be Considered Cured after Autografting for Hodgkin Lymphoma?.

Comparison of 200 cGy vs. 400 cGy Total Body Irradiation (TBI) When Used with Fludarabine for Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation (RIC AHSCT).

Pre-Transplant Hypogammaglobulinemia Influences Survival after Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT).

Long Term Follow Up with Etoposide Priming in Patients with Lymphoma.

Prognostic Impact of Elevated Pretransplant Serum Ferritin in Allogeneic Hematopoietic Stem Cell Transplantation.

Analysis of Factors Influencing Skin Toxicity after Autologous Hematopoeitic Stem Cell Transplant.

Elevated Pretransplant Serum Ferritin in Autologous Stem Cell Transplant.

Disappointing Outcomes of Peripheral T Cell Lymphoma after Autologous Stem Cell Transplantation.

A Quality of Life Assessment of Ablative Allogeneic Bone Marrow Transplant (BMT) Recipients One and Twelve Months after Transplant.

Autologous Stem Cell Transplantation (ABMT) for Recurrent Hodgkin’s Disease from 1990–2005: Factors Contributing to Post-Transplant Relapse.

Improved Post-Transplant Outcomes in Hematologic Malignancy Patients Undergoing Non-Myeloablative Hematopoietic Stem Cell Transplant (NMHSCT) Using a 400 cGy Total Body Irradiation (TBI) Dose with Fludarabine.

High Incidence of Extramedullary Relapses Following Allogeneic Bone Marrow Transplant (Allo-BMT) in Adults with Acute Lymphoblastic Leukemia.

The Prognostic Importance of Pre and Post Dendritic Cells in Autologous Transplantation for Diffuse Large B Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only